misbranding


Also found in: Dictionary, Legal.

misbranding

(mĭs-brănd′ĭng)
Ambiguous, deceptive, false, incomplete, incorrect, or misleading labeling of a drug or medical device.
References in periodicals archive ?
43) Also, it was difficult for the government to prosecute claims of fraud against manufacturers who violated Wiley's Act by misbranding their products.
In Amarin, a pharmaceutical company wanted to promote offlabel uses for one of its drugs, but it did not want to risk misbranding charges.
Notwithstanding these settlements, drug manufacturers have continued to challenge the FDA regulations on misbranding, in particular citing First Amendment protection of commercial speech.
However, the Court left the door slightly ajar to claims alleging parallel violation of the FDA's misbranding prohibition.
The FDA has thus "construed the FDCA to prohibit promotional speech as misbranding itself," Chin wrote.
While the company was ultimately acquitted of Food and Drug Cosmetic Act (FDCA) charges for misbranding and adulteration, the FDCA extends liability to "any person guilty of adulterating or misbranding.
the Federal Food Drug and Cosmetic Act (2) because they "had the responsibility and authority either to prevent in the first instance or to promptly correct certain conduct resulting in the misbranding.
He also faces a maximum fine of $100,000 plus a year in jail on the misdemeanor count of misbranding.
Attorney, and Stryker Biotech, Ard and Whitaker were charged with misbranding.
Nichols Institute pleaded guilty to felony misbranding as part of the criminal case filed against the company and will pay a $40 million fine.
Several other states are mulling similar legislation to protect consumers from misbranding.
the company that makes the narcotic painkiller OxyContin, and three current and former executives pled guilty in federal court to criminal charges of misbranding, a plea accepted by the federal Western District Court of Virginia.